Relationship between homocysteine and thrombotic disease

被引:66
作者
Selhub , J
D'Angelo, A
机构
[1] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[2] Ist Sci San Raffaele, Coagulat Serv, I-20132 Milan, Italy
关键词
homocysteine; folate; vitamins; thrombosis; arteriosclerosis;
D O I
10.1097/00000441-199808000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperhomocysteinemia is a condition which, in the absence of kidney disease, indicates a disrupted sulfur amino acid metabolism, either because of vitamin deficiency (folate, B-12 and B-6) Or a genetic defect;. Epidemiologic evidence suggests that mild hyperhomocysteinemia is associated with increased risk of arteriosclerotic disease and stroke. The relationship between hyperhomocysteinemia and thrombosis has been investigated in 10 studies involving a total of 1200 patients and 1200 controls. Eight of these studies demonstrated positive association with odds ratios that ranged from two to 13. This association was enhanced by including a methionine loading tt:st, There is some evidence which suggests that hyperhomocysteinemia and activated protein C resistance have synergistic effect on the onset of thrombotic disease. Recent studies with animal models for mild hyperhomocysteinemia provided encouraging results in the understanding of the mechanism that underlies this relationship between mild elevations of plasma homocysteine and vascular disease. These animal models pointed to the possibility that the effect of elevated homocysteine is multifactorial, affecting both the vascular wall structure and the blood coagulation system.
引用
收藏
页码:129 / 141
页数:13
相关论文
共 139 条
[1]  
Adams M, 1996, QJM-MON J ASSOC PHYS, V89, P437
[2]   PLASMA HOMOCYSTEINE LEVELS IN PATIENTS WITH DEEP VENOUS THROMBOSIS [J].
AMUNDSEN, T ;
UELAND, PM ;
WAAGE, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1321-1323
[3]  
APPLEGARTH DA, 1971, NEW ENGL J MED, V285, P1265
[4]  
Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818
[5]   ELEVATED TOTAL PLASMA HOMOCYSTEINE, A RISK FACTOR FOR THROMBOSIS - RELATION TO COAGULATION AND FIBRINOLYTIC PARAMETERS [J].
BIENVENU, T ;
ANKRI, A ;
CHADEFAUX, B ;
MONTALESCOT, G ;
KAMOUN, P .
THROMBOSIS RESEARCH, 1993, 70 (02) :123-129
[6]   IMPROVED IDENTIFICATION OF HETEROZYGOTES FOR HOMOCYSTINURIA DUE TO CYSTATHIONINE SYNTHASE DEFICIENCY BY THE COMBINATION OF METHIONINE LOADING AND ENZYME DETERMINATION IN CULTURED FIBROBLASTS [J].
BOERS, GHJ ;
FOWLER, B ;
SMALS, AGH ;
TRIJBELS, FJM ;
LEERMAKERS, AI ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
HUMAN GENETICS, 1985, 69 (02) :164-169
[7]   Treatment of hyperhomocysteinemia in renal transplant recipients - A randomized, placebo-controlled trial [J].
Bostom, AG ;
Gohh, RY ;
Beaulieu, AJ ;
Nadeau, MR ;
Hume, AL ;
Jacques, PF ;
Selhub, J ;
Rosenberg, IH .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (12) :1089-1092
[8]   POST-METHIONINE LOAD HYPERHOMOCYSTEINEMIA IN PERSONS WITH NORMAL FASTING TOTAL PLASMA HOMOCYSTEINE - INITIAL RESULTS FROM THE NHLBI FAMILY HEART-STUDY [J].
BOSTOM, AG ;
JACQUES, PF ;
NADEAU, MR ;
WILLIAMS, RR ;
ELLISON, RC ;
SELHUB, J .
ATHEROSCLEROSIS, 1995, 116 (01) :147-151
[9]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[10]   HOMOCYSTEINE, FACTOR-VII AND ANTITHROMBIN-III IN SUBJECTS WITH DIFFERENT GENE DOSAGE FOR CYSTATHIONINE BETA-SYNTHASE [J].
BRATTSTROM, L ;
ISRAELSSON, B ;
TENGBORN, L ;
HULTBERG, B .
JOURNAL OF INHERITED METABOLIC DISEASE, 1989, 12 (04) :475-482